A Bone-Deep Kinship

A Neanderthal rib fragment provides conclusive evidence that the ancient hominins were susceptible to a benign bone tumor of modern humans.

Written byJef Akst
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

NEANDERTUMOR: The diseased Neanderthal rib (a) shows clear deterioration of the lattice-like structure inside the bone, while in a modern, healthy bone (b) that structure is intact.COURTESY OF PLOS ONE, DOI:10.1371/journal.pone.0064539.g001In the mid-1980s, University of Pennsylvania graduate student Janet Monge and Penn colleague Morrie Kricun undertook a project to X-ray the 900 or so bones of the Krapina collection—Neanderthal remains originally unearthed at the turn of the 20th century a few dozen kilometers north of Zagreb in the former Yugoslavia (now Croatia). For 2 weeks, the team loaded dozens of specimens at a time into individual, form-fitting Styrofoam holders and shuttled them from the Croatian Natural History Museum to the veterinary school in Zagreb, which had made its X-ray equipment available to the researchers. Their goal was to publish a radiographic atlas of the entire collection.

For the most part, the process went smoothly, but there was one X-ray—of an unusually thin and light rib fragment—that appeared “burned out” in the radiographic image, Monge says. Despite using the same amount of radiation as they had for similar specimens, “all of the radiation [went] through the object, rather than being absorbed or reflected by the object, so rather than looking like a bone with white or gray and black sections, it appeared completely black,” she explains. “Immediately we knew something was up with the little fragment.”

The researchers were hopeful that they might be able to lighten the image or increase the contrast to make out some of the bone’s detail, but upon returning to Penn and digitizing the X-rays, Monge had ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Jef (an unusual nickname for Jennifer) got her master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses. After four years of diving off the Gulf Coast of Tampa and performing behavioral experiments at the Tennessee Aquarium in Chattanooga, she left research to pursue a career in science writing. As The Scientist's managing editor, Jef edited features and oversaw the production of the TS Digest and quarterly print magazine. In 2022, her feature on uterus transplantation earned first place in the trade category of the Awards for Excellence in Health Care Journalism. She is a member of the National Association of Science Writers.

    View Full Profile

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies